Cosmos Pharmaceutical Equity 2024

Cosmos Pharmaceutical Aktienanalyse

What does Cosmos Pharmaceutical do?

Cosmos Pharmaceuticals Corp is a Taiwanese company that was founded in 1984. The company specializes in the manufacturing and selling of pharmaceutical and health products, focusing on the needs of patients and healthcare providers. Cosmos Pharmaceuticals Corp has developed a strong business model over the years based on high-quality products, efficient production, and a strong distribution network. The company aims to offer a wide range of products and services to meet customers' needs. It is divided into three main business segments: manufacturing and marketing of drugs, manufacturing and selling of dietary supplements, and sales of medical devices. In the pharmaceutical manufacturing sector, Cosmos Pharmaceuticals Corp offers various drugs, including generics and innovative products that can be used for various conditions such as hypertension, diabetes, and obesity. The company also operates a specialized research center where new active ingredients and therapies are developed. In the dietary supplement sector, Cosmos Pharmaceuticals Corp is known for its products supporting cardiovascular health, immune function, and supplements for the maintenance of hair and skin health. The medical devices division of Cosmos Pharmaceuticals Corp offers a wide range of medical and diagnostic devices, including blood glucose meters, blood pressure monitors, and other devices used by patients and healthcare providers in hospitals and clinics. Furthermore, Cosmos Pharmaceuticals Corp has been committed to quality and customer satisfaction from the beginning. The company has implemented strict quality control standards and a comprehensive quality control system to ensure that all products and services meet the highest standards. The company also has an extensive customer service department that ensures prompt and effective handling of customer inquiries and complaints. Due to its focus on quality products, efficient production, and a strong distribution network, Cosmos Pharmaceuticals Corp has built an excellent reputation over the years. The company has managed to strengthen its presence in Asia and Europe and expand its product range. Cosmos Pharmaceuticals Corp has also established itself as a leading provider of generic and innovative products in Southeast Asia. In summary, Cosmos Pharmaceuticals Corp is a successful and forward-thinking company that strives to meet the needs of its customers and offers a wide range of products and services. With its strong position in the pharmaceutical, dietary supplement, and medical device industries, Cosmos Pharmaceuticals Corp is a company that will continue to grow in the future. Cosmos Pharmaceutical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Cosmos Pharmaceutical's Equity

Cosmos Pharmaceutical's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Cosmos Pharmaceutical's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Cosmos Pharmaceutical's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Cosmos Pharmaceutical's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Cosmos Pharmaceutical’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Cosmos Pharmaceutical stock

What is the equity of Cosmos Pharmaceutical this year?

Cosmos Pharmaceutical has equity of 211.07 B JPY this year.

What was the equity of Cosmos Pharmaceutical compared to the previous year?

The equity of Cosmos Pharmaceutical has increased/decreased by 10.79% increased compared to the previous year.

What impact does a high equity have on investors of Cosmos Pharmaceutical?

A high equity is advantageous for investors of Cosmos Pharmaceutical as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Cosmos Pharmaceutical?

A low equity can be a risk for investors of Cosmos Pharmaceutical, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Cosmos Pharmaceutical affect the company?

An increase in equity of Cosmos Pharmaceutical can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Cosmos Pharmaceutical affect the company?

A reduction in equity of Cosmos Pharmaceutical can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Cosmos Pharmaceutical?

Some factors that can affect the equity of Cosmos Pharmaceutical include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Cosmos Pharmaceutical so important for investors?

The equity of Cosmos Pharmaceutical is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Cosmos Pharmaceutical take to change the equity?

To change equity, Cosmos Pharmaceutical can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Cosmos Pharmaceutical pay?

Over the past 12 months, Cosmos Pharmaceutical paid a dividend of 117.5 JPY . This corresponds to a dividend yield of about 0.92 %. For the coming 12 months, Cosmos Pharmaceutical is expected to pay a dividend of 129.92 JPY.

What is the dividend yield of Cosmos Pharmaceutical?

The current dividend yield of Cosmos Pharmaceutical is 0.92 %.

When does Cosmos Pharmaceutical pay dividends?

Cosmos Pharmaceutical pays a quarterly dividend. This is distributed in the months of December, June, December, June.

How secure is the dividend of Cosmos Pharmaceutical?

Cosmos Pharmaceutical paid dividends every year for the past 22 years.

What is the dividend of Cosmos Pharmaceutical?

For the upcoming 12 months, dividends amounting to 129.92 JPY are expected. This corresponds to a dividend yield of 1.02 %.

In which sector is Cosmos Pharmaceutical located?

Cosmos Pharmaceutical is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Cosmos Pharmaceutical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cosmos Pharmaceutical from 8/1/2024 amounting to 60 JPY, you needed to have the stock in your portfolio before the ex-date on 5/30/2024.

When did Cosmos Pharmaceutical pay the last dividend?

The last dividend was paid out on 8/1/2024.

What was the dividend of Cosmos Pharmaceutical in the year 2023?

In the year 2023, Cosmos Pharmaceutical distributed 82.5 JPY as dividends.

In which currency does Cosmos Pharmaceutical pay out the dividend?

The dividends of Cosmos Pharmaceutical are distributed in JPY.